Nathanael Horne, MD
Allergy & Immunology · New York, NYNPI 1912965435
Payments from drug & device makers
Across 221 payments — averaging $30.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- Optinose US, Inc.$2K
- GSK$767
- Novartis$420
- Kaleo, Inc.$317
- AstraZeneca$267
- plus $1K from 18 others
What the payments were for
- Consulting fees$1,50022%
- Food & beverage$5,23477%
- Education$721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 52 | $2,000 |
| Optinose US, Inc. | 25 | $1,918 |
| GSK | 42 | $767 |
| Novartis | 23 | $420 |
| Kaleo, Inc. | 15 | $317 |
| AstraZeneca | 12 | $267 |
| Biocryst US Sales Co., LLC | 7 | $219 |
| ARS Pharmaceuticals Operations, Inc. | 14 | $215 |
| Incyte Corporation | 5 | $102 |
| Amgen | 5 | $89 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Grifols USA, LLC | 3 | $60 |
| Phadia US Inc. | 3 | $58 |
| Blueprint Medicines Corporation | 2 | $56 |
| Pfizer | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| CSL Behring | 1 | $29 |
| AbbVie | 1 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $26 |
| Antares Pharma, Inc. | 1 | $22 |
| Covis Pharma GmbH | 1 | $19 |
| Ionis Pharmaceuticals, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| GC Biopharma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,806 in reported general payments places this provider in the 65th percentile of 320 allergy & immunology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 16 | $64,019 |
| Epinephrine | 17 | $3,777 |
| Azelastine Hcl | 64 | $2,122 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $1,191 |
| Fluticasone Propionate | 21 | $578 |
| Montelukast Sodium | 26 | $339 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in New York
- Ujwala KazaNew York$1.1M
- Robert SporterNew York$980K
- Paula BusseNew York$821K
- Richard InselNew York$269K
- Joyce YuNew York$209K
- Arthur LubitzNew York$196K
- Purvi ParikhNew York$196K
- Charlotte Cunningham-RundlesNew York$180K
- Ama AlexisNew York$120K
- Zoya TreysterNew York$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.